These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
376 related articles for article (PubMed ID: 9628583)
1. Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. Rieber M; Strasberg Rieber M DNA Cell Biol; 1998 May; 17(5):399-406. PubMed ID: 9628583 [TBL] [Abstract][Full Text] [Related]
2. Signalling responses linked to betulinic acid-induced apoptosis are antagonized by MEK inhibitor U0126 in adherent or 3D spheroid melanoma irrespective of p53 status. Rieber M; Rieber MS Int J Cancer; 2006 Mar; 118(5):1135-43. PubMed ID: 16152620 [TBL] [Abstract][Full Text] [Related]
3. Suppression of C8161 melanoma metastatic ability by chromosome 6 induces differentiation-associated tyrosinase and decreases proliferation on adhesion-restrictive substrates mediated by overexpression of p21WAF1 and down-regulation of bcl-2 and cyclin D3. Strasberg Rieber M; Welch DR; Rieber M Biochem Biophys Res Commun; 2001 Feb; 281(1):159-65. PubMed ID: 11178974 [TBL] [Abstract][Full Text] [Related]
4. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid. Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934 [TBL] [Abstract][Full Text] [Related]
5. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells. Strasberg Rieber M; Welch DR; Miele ME; Rieber M Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203 [TBL] [Abstract][Full Text] [Related]
6. Betulinic acid-induced programmed cell death in human melanoma cells involves mitogen-activated protein kinase activation. Tan Y; Yu R; Pezzuto JM Clin Cancer Res; 2003 Jul; 9(7):2866-75. PubMed ID: 12855667 [TBL] [Abstract][Full Text] [Related]
7. Correspondence re: S. Fulda et al., Betulinic acid triggers CD95 (Apo1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res., 57: 4956-4964, 1997. Rieber M; Rieber MS Cancer Res; 1998 Dec; 58(24):5876-7. PubMed ID: 9865749 [No Abstract] [Full Text] [Related]
8. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621 [TBL] [Abstract][Full Text] [Related]
9. Effects of betulinic acid alone and in combination with irradiation in human melanoma cells. Selzer E; Pimentel E; Wacheck V; Schlegel W; Pehamberger H; Jansen B; Kodym R J Invest Dermatol; 2000 May; 114(5):935-40. PubMed ID: 10771474 [TBL] [Abstract][Full Text] [Related]
10. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Pisha E; Chai H; Lee IS; Chagwedera TE; Farnsworth NR; Cordell GA; Beecher CW; Fong HH; Kinghorn AD; Brown DM Nat Med; 1995 Oct; 1(10):1046-51. PubMed ID: 7489361 [TBL] [Abstract][Full Text] [Related]
11. Polyamine analogue induction of the p53-p21WAF1/CIP1-Rb pathway and G1 arrest in human melanoma cells. Kramer DL; Vujcic S; Diegelman P; Alderfer J; Miller JT; Black JD; Bergeron RJ; Porter CW Cancer Res; 1999 Mar; 59(6):1278-86. PubMed ID: 10096560 [TBL] [Abstract][Full Text] [Related]
12. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. Raisova M; Hossini AM; Eberle J; Riebeling C; Wieder T; Sturm I; Daniel PT; Orfanos CE; Geilen CC J Invest Dermatol; 2001 Aug; 117(2):333-40. PubMed ID: 11511312 [TBL] [Abstract][Full Text] [Related]
13. Induction of cell cycle arrest and apoptosis by betulinic acid-rich fraction from Dillenia suffruticosa root in MCF-7 cells involved p53/p21 and mitochondrial signalling pathway. Foo JB; Saiful Yazan L; Tor YS; Wibowo A; Ismail N; How CW; Armania N; Loh SP; Ismail IS; Cheah YK; Abdullah R J Ethnopharmacol; 2015 May; 166():270-8. PubMed ID: 25797115 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia increases the apoptotic response to betulinic acid and betulin in human non-small cell lung cancer cells. Kutkowska J; Strzadala L; Rapak A Chem Biol Interact; 2021 Jan; 333():109320. PubMed ID: 33181113 [TBL] [Abstract][Full Text] [Related]
15. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Fulda S; Friesen C; Los M; Scaffidi C; Mier W; Benedict M; Nuñez G; Krammer PH; Peter ME; Debatin KM Cancer Res; 1997 Nov; 57(21):4956-64. PubMed ID: 9354463 [TBL] [Abstract][Full Text] [Related]
16. Tumor suppression without differentiation or apoptosis by antisense cyclin D1 gene transfer in K1735 melanoma involves induction of p53, p21WAF1 and superoxide dismutases. Rieber M; Rieber MS Cell Death Differ; 1999 Dec; 6(12):1209-15. PubMed ID: 10637437 [TBL] [Abstract][Full Text] [Related]
17. Betulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways. Shankar E; Zhang A; Franco D; Gupta S Molecules; 2017 Feb; 22(2):. PubMed ID: 28208611 [TBL] [Abstract][Full Text] [Related]
18. Betulinic acid suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase SHP-1 in human multiple myeloma cells. Pandey MK; Sung B; Aggarwal BB Int J Cancer; 2010 Jul; 127(2):282-92. PubMed ID: 19937797 [TBL] [Abstract][Full Text] [Related]
19. [Effect of betulinic acid on proliferation and apoptosis in Jurkat cells and its mechanism]. Chen Z; Wu QL; Chen Y; He J Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):588-92. PubMed ID: 19102935 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma. Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]